載入...
Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
Over 80% of triple negative breast cancers express mutant p53. Mutant p53 often gains oncogenic function suggesting that triple negative breast cancers may be driven by p53 protein type. To determine the chromatin targets of this gain-of-function mutant p53 we used inducible knockdown of endogenous...
Na minha lista:
| 發表在: | NPJ Breast Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319483/ https://ncbi.nlm.nih.gov/pubmed/28232952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-016-0001-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|